NBP · Insider trading · 13F holders · Congress trades
NovaBridge Biosciences (NBP)
Who is buying and selling NBP: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $88K
- Congress trades, 12 months
- 0
NBP at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 NBP insiders filed 3 sales worth $88K on SEC Form 4, and no open-market purchases.
- No 13F filer reports NBP among its 50 largest positions.
- No member of Congress has disclosed a trade in NBP.
- NBP last closed at $1.21 on Oct 29, 2026.
NBP insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 NBP insiders filed 3 sales worth $88K on SEC Form 4, and no open-market purchases.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Dennis Phillip Andrew | Chief Medical Officer | Sale | 8,209 | $0.71 | $6K | SEC |
| Sep 11, 2026 | Cao Sean Wuxiong | Chief Bus. Development Officer | Sale | 107,978 | $0.74 | $80K | SEC |
| Sep 1, 2026 | Xu Cong Claire | EVP, Clinical Development | Sale | 3,282 | $0.79 | $3K | SEC |
Who owns NBP? Hedge funds and superinvestors
No 13F filer reports NBP among its 50 largest positions.
NBP stock trades by members of Congress
No member of Congress has disclosed a trade in NBP.
NBP questions and answers
Are insiders buying NBP stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 NBP insiders filed 3 sales worth $88K on SEC Form 4, and no open-market purchases.
Which hedge funds own NBP?
No 13F filer reports NBP among its 50 largest positions.
Has Congress traded NBP?
No member of Congress has disclosed a trade in NBP.
Cite or share this
Free to use with a link back. The data updates every filing day.